Pharmaceutical Products for CDER Research Studies - IDIQ
This opportunity is for a follow-on contract to provide services previously performed by WE Pharma, LLC. The prior contract had a total ceiling value of $9,500,000.00 and a period of performance from September 30, 2020, to September 29, 2025. No specific budget amount for the new contract is provided in the description. The location for performance of services is not specified. Prospective bidders should review the attached combined synopsis/solicitation and amendment for full details.